European Atherosclerosis Society Rises to the Challenge of the Underdiagnosis and Undertreatment of Familial Hypercholesterolaemia

The European Atherosclerosis Society announces the launch of the global EAS FH Studies Collaboration (FHSC), which aims to address gaps in FH care and education worldwide. The mission of the EAS FHSC is to empower the medical and global community to seek change in how FH is detected and managed, so as to promote early diagnosis and more effective treatment of this condition. 

Lead of the FHSC initiative, Professor Kausik Ray (Imperial College London, UK), said: ‘This is a unique opportunity for us to change the lives of millions of people around the world by working as one and leave a lasting benefit for future generations. Through international collaboration with stakeholders we aim to generate large scale robust data on how FH is detected, managed and the clinical consequences of current practice on outcomes. We will work with all stakeholders including patient’s organisations to ensure that state-of-the-art information is utilised to close gaps in knowledge and/or improve clinical practice for our FH patients.’ 

Professor Ray leads an International Steering Committee comprising Dr Handrean Soran (UK); Professor John Kastelein, Professor G.Kees Hovingh (Netherlands); Professor Pedro Mata (Spain); Professor Gerald Watts (Australia); Professor Frederick Raal (South Africa); Professor Raul Santos (Brazil); and EAS President Professor Alberico L. Catapano (Italy). 

Currently, more than 30 countries have already agreed to take part. 

The FHSC was officially launched at a European Board for Accreditation in Cardiology (EBAC) accredited Congress session on Sunday 22 March at 10:00 am